肠促胰岛素相关药物的全球市场：按药物类型、给药途径、适应症、地区和国家、市场考察和预测进行分析

全球肠促胰岛素相关药物市场规模预计将从 2022 年的 407.2 亿美元增至 2029年终的 642.8 亿美元，2024-2029 年预测期间复合年增长率为 6.8%。

全球 2 型糖尿病盛行率的不断上升对肠促胰岛素相关药物的需求产生了重大影响。糖尿病盛行率的增加是由多种因素造成的，包括久坐的生活方式、不良的饮食习惯和高龄化。

与许多其他抗高血糖药物相比，肠促胰岛素相关药物具有几个显着的优点，包括没有低血糖或体重增加的风险。 DPP4I和GLP-1RA表现出独特的疗效和耐受性，使医生能够考虑疾病状况（以HbA1c百分比表示）、体重以及患者对自行注射药物的偏好等因素，为患者选择最合适的药物每个病人。随着学名药和给药减少的改进配方的推出，市场上的重磅药物变得可用，肠促胰岛素相关药物的需求预计将呈指数级增长。

该报告审视了全球肠促胰岛素相关药物市场，并提供了包括市场规模和预测、区域和细分市场分析以及主要趋势和机会在内的资讯。

目录

第一章 市集背景

• 产品范围和产品前景
• 执行摘要
• 调查方法

第二章 战略建议

第三章全球肠促胰岛素相关药物市场：实绩与预测（2018-2028）

• 世界肥胖统计（2022）
• 肠促胰岛素相关药物的管线分析
• 全球糖尿病盛行率最高的国家（2021年）
• 全球糖尿病患者估计人数（2000-2014E）
• 全球肠促胰岛素相关药物市场：仪表板
• 全球肠促胰岛素相关药物市场：市场金额评估（2018-2028）
• COVID-19对全球肠促胰岛素相关药物市场的影响
• 全球肠促胰岛素相关药物市场区隔：依药物类型
  • 全球肠促胰岛素相关药物市场：依药物类型概述
  • 全球肠促胰岛素相关药物、Glucagon-Like Peptide-1受体促效剂市场规模（金额）（2018-2028）
  • 全球肠促胰岛素相关药物、Dipeptidyl Peptidase-4抑制剂市场规模（金额）（2018-2028）
• 按给药途径分類的全球肠促胰岛素相关药物市场区隔
  • 全球肠促胰岛素相关药物市场：依给药途径概述
  • 全球口服肠促胰岛素相关药物市场规模（金额）（2018-2028）
  • 全球肠促胰岛素相关药物、注射剂市场规模（金额）（2018-2028）
• 全球肠促胰岛素相关药物市场区隔：按适应症
  • 全球肠促胰岛素相关药物市场：按适应症概述
  • 全球糖尿病肠促胰岛素相关药物市场规模（金额）（2018-2028）
  • 全球肠促胰岛素相关药物、肥胖市场规模（金额）（2018-2028）

第四章全球肠促胰岛素相关药物市场、区域分析

• 研究区域范围
• 区域简介

第五章北美与南美肠促胰岛素相关药物市场：实绩与预测（2018-2028）

• 美洲肠促胰岛素药物市场：概况
• 美洲肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
• 美洲肠促胰岛素相关药物市场：关键驱动因素
• 美洲肠促胰岛素相关药物市场：細項分析
• 按药物类型分類的美洲肠促胰岛素药物市场区隔
• 美洲肠促胰岛素相关药物市场区隔：依给药途径
• 美洲肠促胰岛素相关药物市场区隔：依适应症分类
• 美洲肠促胰岛素相关药物市场区隔：按国家/地区
  • 美国肠促胰岛素相关药物市场：市场规模及复合年增长率（2018-2028）
  • 加拿大肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 北美和南美其他肠促胰岛素相关药物市场：市场规模和复合年增长率（2018-2028）

第六章欧洲肠促胰岛素相关药物市场：实绩与预测（2018-2028）

• 欧洲肠促胰岛素药物市场：概况
• 欧洲肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
• 欧洲肠促胰岛素相关药物市场：关键驱动因素
• 欧洲肠促胰岛素相关药物市场：細項分析
• 欧洲肠促胰岛素相关药物市场区隔：依药物类型
• 欧洲肠促胰岛素相关药物市场区隔依给药途径细分
• 欧洲肠促胰岛素相关药物市场区隔：按适应症
• 欧洲肠促胰岛素相关药物市场区隔：依国家/地区
  • 德国肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 英国肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 法国肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 义大利肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 西班牙肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 其他欧洲肠促胰岛素相关药物市场：市场规模及复合年增长率（2018-2028）

第七章亚太肠促胰岛素相关药物市场：实绩与预测（2018-2028）

• 亚太肠促胰岛素药物市场：概况
• 亚太肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
• 亚太肠促胰岛素相关药物市场：主要驱动力
• 亚太地区肠促胰岛素相关药物市场：細項分析
• 亚太地区肠促胰岛素相关药物市场区隔：依药物类型
• 按给药途径分類的亚太地区肠促胰岛素相关药物市场区隔
• 亚太地区肠促胰岛素相关药物市场区隔：按适应症
• 亚太地区肠促胰岛素相关药物市场区隔：依国家/地区
  • 中国肠促胰岛素相关药物市场：市场规模及复合年增长率（2018-2028）
  • 日本肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 印度肠促胰岛素相关药物市场：市场规模与复合年增长率（2018-2028）
  • 其他亚太肠促胰岛素相关药物市场：市场规模及复合年增长率（2018-2028）

第八章中东和非洲肠促胰岛素相关药物市场：实绩和预测（2018-2028）

• 中东和非洲肠促胰岛素相关药物市场：概况
• 中东和非洲肠促胰岛素相关药物市场：市场规模和复合年增长率（2018-2028）
• 中东和非洲肠促胰岛素药物市场：关键因素
• 中东和非洲肠促胰岛素相关药物市场：細項分析
• 中东和非洲肠促胰岛素相关药物市场区隔：按药物类型
• 中东和非洲肠促胰岛素相关药物市场区隔：按给药途径
• 中东及非洲肠促胰岛素相关药物市场区隔：依适应症分类

第九章市场动态

• 评估市场动态对全球肠促胰岛素相关药物市场的影响
• 促进因素
• 抑制因素
• 趋势

第10章波特五力分析

第十一章竞争定位

• 企业产品定位
• 市场地位矩阵
• 肠促胰岛素相关药物市场占有率分析
• 公司简介
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Novo Nordisk
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer
  • Novartis AG
  • Takeda Pharmaceuticals
  • Bristol Myers Squibb
  • Structure Therapeutics

Executive Summary

Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), By Route of Administration (Oral, Injectables) and By Indication (Diabetes, Obesity) for the historical period of 2018-2022, the estimated year of 2023 and the forecast period of 2024-2028.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Incretin Based Drugs market is expected to grow at a CAGR of 6.8%. The Global Incretin Based Drugs Market is expected to generate USD 64.28 billion by the end of 2029, up from USD 40.72 Billion in 2022.

Incretin-based drugs are the first-of-its-kind anti-hyperglycemic medications that have been developed by specifically targeting a recognized pathophysiological abnormality in type 2 diabetes. The global increase in the prevalence of type 2 diabetes has a significant impact on the demand for incretin-based drugs. The growing incidence of diabetes can be attributed to various factors, including sedentary lifestyles, poor dietary habits, and the ageing demographic.

In comparison to many other anti-hyperglycemic medications, incretin-based drugs offer some notable benefits, including the lack of an elevated risk of hypoglycemia or weight gain. The DPP4Is and GLP-1RAs exhibit unique efficacy and tolerability profiles, providing physicians with the opportunity to choose the most suitable medication for each patient, taking into account factors such as disease status (as indicated by HbA1c percentage), body weight, and patient preference for self-administered injectable drugs. The demand for Incretin-based drugs is expected to grow exponentially as the blockbuster drugs in the market become accessible in generic form and as upgraded formulations with reduced dosing frequency are introduced.

Scope of the Report

• The report analyses the Incretin Based Drugs Market by Value (USD Billion).
• The report presents the analysis of Incretin Based Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Incretin-Based Drugs Market by Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors).
• The report analyses the Incretin Based Drugs Market by Route of Administration (Oral, Injectables)
• The report analyses the Incretin-Based Drugs Market by Indication (Diabetes, Obesity).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Drug Type, By Route of Administration and by Indications.
• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, AstraZeneca PLC, Merck & Co., Inc., Pfizer, Novartis AG, Takeda Pharmaceuticals, Bristol Myers Squibb, Structure Therapeutics.

Table of Contents

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Strategic Recommendations

3. Global Incretin Based Drugs Market: Historic and Forecast (2018-2028)

• 3.1 Global Obesity Statistics 2022, in Millions
• 3.2 Pipeline Analysis of Incretin based drugs
• 3.3 Countries with the highest prevalence of diabetes worldwide in 2021
• 3.4 Estimated number of individuals with Diabetes Worldwide, in thousands (2000-2014E)
• 3.5 Global Incretin-Based Drugs Market: Dashboard
• 3.6 Global Incretin Based Drugs Market: Market Value Assessment, 2018-2028 (USD Billion)
• 3.7 Impact of COVID-19 on Global Incretin Based Drugs Market
• 3.8 Global Incretin-Based Drugs Market Segmentation: By Drug Type
  • 3.8.1 Global Incretin-Based Drugs Market, By Drug Type Overview
  • 3.8.2 Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
  • 3.8.3 Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
• 3.9 Global Incretin-Based Drugs Market Segmentation: By Route of Administration
  • 3.9.1 Global Incretin-Based Drugs Market, By Route of Administration Overview
  • 3.9.2 Global Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
  • 3.9.3 Global Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
• 3.10 Global Incretin Based Drugs Market Segmentation: By Indication
  • 3.10.1 Global Incretin Based Drugs Market, By Indication Overview
  • 3.10.2 Global Incretin Based Drugs Market Size, By Diabetes By Value, 2018H-2028F (USD Billion & CAGR)
  • 3.10.3 Global Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)

4. Global Incretin Based Drugs Market, Region Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Incretin Based Drugs Market: Historic and Forecast (2018-2028)

• 5.1 Americas Incretin-Based Drugs Market: Snapshot
• 5.2 Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
• 5.3 Americas Incretin-Based Drugs Market: Key Factors
• 5.4 Americas Incretin-Based Drugs Market: Segment Analysis
• 5.5 Americas Incretin-Based Drugs Market Segmentation: By Drug Type
  • 5.5.1 Americas Incretin-Based Drugs Market, By Drug Type Overview
  • 5.5.2 Americas Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
  • 5.5.3 Americas Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
• 5.6 Americas Incretin-Based Drugs Market Segmentation: By Route of Administration
  • 5.6.1 Americas Incretin-Based Drugs Market, By Route of Administration Overview
  • 5.6.2 Americas Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
  • 5.6.3 Americas Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
• 5.7 Americas Incretin-Based Drugs Market Segmentation: By Indication
  • 5.7.1 Americas Incretin-Based Drugs Market, By Indication Overview
  • 5.7.2 Americas Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
  • 5.7.3 Americas Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
• 5.8 Americas Incretin-Based Drugs Market Segmentation: By Country
  • 5.8.1 United States Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 5.8.1.1 United States Incretin-Based Drugs Market, By Drug Type
    • 5.8.1.2 United States Incretin-Based Drugs Market, By Route of Administration
    • 5.8.1.3 United States Incretin-Based Drugs Market, By Indication
  • 5.8.2 Canada Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 5.8.2.1 Canada Incretin-Based Drugs Market, By Drug Type
    • 5.8.2.2 Canada Incretin-Based Drugs Market, By Route of Administration
    • 5.8.2.3 Canada Incretin-Based Drugs Market, By Indication
  • 5.8.3 Rest of Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 5.8.3.1 Rest of Americas Incretin-Based Drugs Market, By Drug Type
    • 5.8.3.2 Rest of Americas Incretin-Based Drugs Market, By Route of Administration
    • 5.8.3.3 Rest of Americas Incretin-Based Drugs Market, By Indication

6. Europe Incretin Based Drugs Market: Historic and Forecast (2018-2028)

• 6.1 Europe Incretin-Based Drugs Market: Snapshot
• 6.2 Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
• 6.3 Europe Incretin-Based Drugs Market: Key Factors
• 6.4 Europe Incretin-Based Drugs Market: Segment Analysis
• 6.5 Europe Incretin-Based Drugs Market Segmentation: By Drug Type
  • 6.5.1 Europe Incretin-Based Drugs Market, By Drug Type Overview
  • 6.5.2 Europe Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
  • 6.5.3 Europe Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
• 6.6 Europe Incretin-Based Drugs Market Segmentation: By Route of Administration
  • 6.6.1 Europe Incretin-Based Drugs Market, By Route of Administration Overview
  • 6.6.2 Europe Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
  • 6.6.3 Europe Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
• 6.7 Europe Incretin-Based Drugs Market Segmentation: By Indication
  • 6.7.1 Europe Incretin-Based Drugs Market, By Indication Overview
  • 6.7.2 Europe Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
  • 6.7.3 Europe Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
• 6.8 Europe Incretin-Based Drugs Market Segmentation: By Country
  • 6.8.1 Germany Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 6.8.1.1 Germany Incretin-Based Drugs Market, By Drug Type
    • 6.8.1.2 Germany Incretin Based Drugs Market, By Route of Administration
    • 6.8.1.3 Germany Incretin Based Drugs Market, By Indication
  • 6.8.2 United Kingdom Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 6.8.2.1 United Kingdom Incretin Based Drugs Market, By Drug Type
    • 6.8.2.2 United Kingdom Incretin Based Drugs Market, By Route of Administration
    • 6.8.2.3 United Kingdom Incretin Based Drugs Market, By Indication
  • 6.8.3 France Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 6.8.3.1 France Incretin Based Drugs Market, By Drug Type
    • 6.8.3.2 France Incretin Based Drugs Market, By Route of Administration
    • 6.8.3.3 France Incretin Based Drugs Market, By Indication
  • 6.8.4 Italy Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 6.8.4.1 Italy Incretin Based Drugs Market, By Drug Type
    • 6.8.4.2 Italy Incretin Based Drugs Market, By Route of Administration
    • 6.8.4.3 Italy Incretin Based Drugs Market, By Indication
  • 6.8.5 Spain Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 6.8.5.1 Spain Incretin Based Drugs Market, By Drug Type
    • 6.8.5.2 Spain Incretin Based Drugs Market, By Route of Administration
    • 6.8.5.3 Spain Incretin Based Drugs Market, By Indication
  • 6.8.6 Rest of Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 6.8.6.1 Rest of Europe Incretin-Based Drugs Market, By Drug Type
    • 6.8.6.2 Rest of Europe Incretin-Based Drugs Market, By Route of Administration
    • 6.8.6.3 Rest of Europe Incretin-Based Drugs Market, By Indication

7. Asia-Pacific Incretin Based Drugs Market: Historic and Forecast (2018-2028)

• 7.1 Asia-Pacific Incretin Based Drugs Market: Snapshot
• 7.2 Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
• 7.3 Asia-Pacific Incretin Based Drugs Market: Key Factors
• 7.4 Asia-Pacific Incretin Based Drugs Market: Segment Analysis
• 7.5 Asia-Pacific Incretin Based Drugs Market Segmentation: By Drug Type
  • 7.5.1 Asia-Pacific Incretin Based Drugs Market, By Drug Type Overview
  • 7.5.2 Asia-Pacific Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
  • 7.5.3 Asia-Pacific Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
• 7.6 Asia-Pacific Incretin Based Drugs Market Segmentation: By Route of Administration
  • 7.6.1 Asia-Pacific Incretin Based Drugs Market, By Route of Administration Overview
  • 7.6.2 Asia-Pacific Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
  • 7.6.3 Asia-Pacific Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
• 7.7 Asia-Pacific Incretin Based Drugs Market Segmentation: By Indication
  • 7.7.1 Asia-Pacific Incretin Based Drugs Market, By Indication Overview
  • 7.7.2 Asia-Pacific Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
  • 7.7.3 Asia-Pacific Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
• 7.8 Asia-Pacific Incretin Based Drugs Market Segmentation: By Country
  • 7.8.1 China Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 7.8.1.1 China Incretin Based Drugs Market, By Drug Type
    • 7.8.1.2 China Incretin Based Drugs Market, By Route of Administration
    • 7.8.1.3 China Incretin Based Drugs Market, By Indication
  • 7.8.2 Japan Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 7.8.1.1 Japan Incretin Based Drugs Market, By Drug Type
    • 7.8.1.2 Japan Incretin Based Drugs Market, By Route of Administration
    • 7.8.1.3 Japan Incretin Based Drugs Market, By Indication
  • 7.8.3 India Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 7.8.3.1 India Incretin Based Drugs Market, By Drug Type
    • 7.8.3.2 India Incretin Based Drugs Market, By Route of Administration
    • 7.8.3.3 India Incretin Based Drugs Market, By Indication
  • 7.8.5 Rest of Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
    • 7.8.5.1 Rest of Asia-Pacific Incretin Based Drugs Market, By Drug Type
    • 7.8.5.2 Rest of Asia-Pacific Incretin Based Drugs Market, By Route of Administration
    • 7.8.5.3 Rest of Asia-Pacific Incretin Based Drugs Market, By Indication

8. Middle-East & Africa Incretin Based Drugs Market: Historic and Forecast (2018-2028)

• 8.1 Middle-East & Africa Incretin Based Drugs Market: Snapshot
• 8.2 Middle-East & Africa Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
• 8.3 Middle-East & Africa Incretin Based Drugs Market: Key Factors
• 8.4 Middle-East & Africa Incretin Based Drugs Market: Segment Analysis
• 8.5 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Drug Type
  • 8.5.1 Middle-East & Africa Incretin Based Drugs Market, By Drug Type Overview
  • 8.5.2 Middle-East & Africa Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
  • 8.5.3 Middle-East & Africa Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
• 8.6 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Route of Administration
  • 8.6.1 Middle-East & Africa Incretin Based Drugs Market, By Route of Administration Overview
  • 8.6.2 Middle-East & Africa Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
  • 8.6.3 Middle-East & Africa Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
• 8.7 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Indication
  • 8.7.1 Middle-East & Africa Incretin Based Drugs Market, By Indication: Overview
  • 8.7.2 Middle-East & Africa Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
  • 8.7.3 Middle-East & Africa Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact Assessment of Market Dynamics on Global Incretin-Based Drugs Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Porter's Five Forces Analysis

• 10.1 Porter's Five Forces Model

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Position Matrix
• 11.3 Market Share Analysis of Incretin-Based Drugs Market
• 11.4 Company Profiles
  • 11.4.1 Eli Lilly and Company
  • 11.4.2 Boehringer Ingelheim
  • 11.4.3 Novo Nordisk
  • 11.4.4 AstraZeneca PLC
  • 11.4.5 Merck & Co., Inc.
  • 11.4.6 Pfizer
  • 11.4.7 Novartis AG
  • 11.4.8 Takeda Pharmaceuticals
  • 11.4.9 Bristol Myers Squibb
  • 11.4.10 Structure Therapeutics

List of Figures

List of Figures

• Figure 1: Global obesity statistics 2022(In Millions)
• Figure 2: Countries with the highest prevalence of diabetes worldwide in 2021
• Figure 3: People with diabetes in Thousands, (20-79 y)
• Figure 4: Global Incretin Based Drugs Market Size, By Value, 2019-2022 (USD Billion)
• Figure 5: Global Incretin Based Drugs Market Size, By Value, 2023-2029 (USD Billion)
• Figure 6: Global Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
• Figure 7: Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 8: Global Incretin Based Drugs Market Absolute Opportunity, By Glucagon-like Peptide-1 Receptor Agonists, 2019-2029 (USD Billion)
• Figure 9: Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 10: Global Incretin Based Drugs Market Absolute Opportunity, By Dipeptidyl Peptidase-4 Inhibitors, 2019-2029 (USD Billion)
• Figure 11: Global Incretin Based Drugs Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 12: Global Incretin Based Drugs Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
• Figure 13: Global Incretin Based Drugs Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 14: Global Incretin Based Drugs Market Absolute Opportunity, By Injectables, 2019-2029 (USD Billion)
• Figure 15: Global Incretin Based Drugs Market Size, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 16: Global Incretin Based Drugs Market Absolute Opportunity, By Diabetes, 2019-2029 (USD Billion)
• Figure 17: Global Incretin Based Drugs Market Size, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 18: Global Incretin Based Drugs Market Absolute Opportunity, By Obesity, 2019-2029 (USD Billion)
• Figure 19: Americas Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 20: Americas Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
• Figure 21: Americas Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 22: Americas Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 23: Americas Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 24: Americas Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 25: Americas Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 26: Americas Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 27: United States Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 28: United States Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 29: United States Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 30: United States Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
• Figure 31: United States Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 32: Canada Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 33: Canada Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 34: Canada Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 35: Canada Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 36: Canada Incretin Based Drugs Market Share, Indication, 2022 (%)
• Figure 37: Rest of Americas Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 38: Rest of Americas Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 39: Rest of Americas Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 40: Rest of Americas Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 41: Rest of Americas Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 42: Europe Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 43: Europe Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
• Figure 44: Europe Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 45: Europe Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 46: Europe Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 47: Europe Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 48: Europe Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 49: Europe Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 50: Germany Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 51: Germany Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 52: Germany Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 53: Germany Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
• Figure 54: Germany Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 55: United Kingdom Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 56: United Kingdom Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 57: United Kingdom Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 58: United Kingdom Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
• Figure 59: United Kingdom Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 60: France Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 61: France Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 62: France Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 63: France Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
• Figure 64: France Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 65: Italy Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 66: Italy Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 67: Italy Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 68: Italy Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 69: Italy Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 70: Spain Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 71: Spain Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 72: Spain Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 73: Spain Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 74: Spain Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 75: Rest of Europe Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 76: Rest of Europe Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 77: Rest of Europe Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 78: Rest of Europe Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 79: Rest of Europe Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 80: Asia Pacific Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 81: Asia Pacific Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
• Figure 82: Asia Pacific Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 83: Asia Pacific Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 84: Asia Pacific Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 85: Asia Pacific Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 86: Asia Pacific Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 87: Asia Pacific Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 88: China Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 89: China Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 90: China Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 91: China Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 92: China Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 93: Japan Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 94: Japan Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 95: Japan Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 96: Japan Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 97: Japan Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 98: India Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 99: India Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 100: India Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 101: India Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 102: India Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 103: Rest of Asia Pacific Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
• Figure 104: Rest of Asia Pacific Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
• Figure 105: Rest of Asia Pacific Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
• Figure 106: Rest of Asia Pacific Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
• Figure 107: Rest of Asia Pacific Incretin Based Drugs Market Share, By Indication, 2022 (%)
• Figure 108: Middle East and Africa Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 109: Middle East and Africa Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
• Figure 110: Middle East and Africa Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 111: Middle East and Africa Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 112: Middle East and Africa Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 113: Middle East and Africa Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 114: Middle East and Africa Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 115: Middle East and Africa Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 116: Market Share of Prominent Companies of Incretin Based Drugs Market, 2022 (%)
• Figure 117: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
• Figure 118: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
• Figure 119: Eli Lilly and Company Revenue, By Therapeutic Area, 2022 (%)
• Figure 120: Novo Nordisk Revenues, 2020-2022 (USD Million)
• Figure 121: Novo Nordisk Revenues, By Geographic Segments, 2022 (%)
• Figure 122: Novo Nordisk Revenue, By Therapeutic Area, 2022 (%)
• Figure 123: AstraZeneca PLC Revenues, 2020-2022 (USD Million)
• Figure 124: AstraZeneca PLC Revenues, By Geographic Segments, 2022 (%)
• Figure 125: AstraZeneca PLC Revenue, By Business Segments, 2022 (%)
• Figure 126: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
• Figure 127: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
• Figure 128: Merck & Co., Inc. Revenue, By Business Segments, 2022 (%)
• Figure 129: Pfizer Revenues, 2020-2022 (USD Million)
• Figure 130: Pfizer Revenues, By Business Segments, 2022 (%)
• Figure 131: Pfizer Inc. Revenue, By Geographical Segments, 2022 (%)
• Figure 132: Novartis Revenue, 2020-2022 (USD Million)
• Figure 133: Novartis Revenue, By Business Segments, 2022 (%)
• Figure 134: Novartis Revenue, By Geographical Segments, 2022 (%)
• Figure 135: Takeda Pharmaceuticals Revenues, 2019-2021 (USD Million)
• Figure 136: Takeda Pharmaceuticals Revenues, By Geographic Segments, 2021 (%)
• Figure 137: Takeda Pharmaceuticals Revenue, By Business Segments, 2021 (%)
• Figure 138: Bristol-Myers Squibb Revenues, 2020-2022 (USD Million)
• Figure 139: Bristol-Myers Squibb Revenues, By Geographic Segments, 2022 (%)

List of Tables

Table A1: Incretin based drugs in Several stages of clinical trials

Table A2: United States Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A3: United States Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A4: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A5: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A6: United States Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A7: United States Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A8: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A9: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A10: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A11: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A12: Canada Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A13: Canada Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A14: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A15: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A16: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A17: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A18: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A19: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A20: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A21: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A22: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A23: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A24: Germany Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A25: Germany Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A26: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A27: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A28: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A29: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A30: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A31: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A32: France Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A33: France Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A34: France Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A35: France Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A36: France Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A37: France Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A38: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A39: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A40: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A41: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A42: Italy Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A43: Italy Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A44: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A45: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A46: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A47: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A48: Spain Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A49: Spain Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A50: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A51: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A52: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A53: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A54: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A55: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A56: China Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A57: China Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A58: China Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A59: China Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A60: China Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A61: China Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A62: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A63: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A64: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A65: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A66: Japan Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A67: Japan Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A68: India Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A69: India Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A70: India Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A71: India Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A72: India Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A73: India Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A74: Rest of Asia Pacific Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A75: Rest of Asia Pacific Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A76: Rest of Asia Pacific Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A77: Rest of Asia Pacific Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A78: Rest of Asia Pacific Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A79: Rest of Asia Pacific Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A80: Eli Lilly and Company Key Financials, 2020-2022

Table A81: Novo Nordisk Key Financials, 2020-2022

Table A82: AstraZeneca PLC Key Financials, 2020-2022

Table A83: Merck & Co., Inc. Key Financials, 2020-2022

Table A84: Pfizer Key Financials, 2020-2022

Table A85: Novartis Key Company Financials, 2020-2022

Table A86: Takeda Pharmaceuticals Key Financials, 2020-2022

Table A87: Bristol-Myers Squibb Key Financials, 2020-2022